IDE Group’s Post

The latest BHI E-Newsletter is live! This week we are sharing stories including: 🩺 United Therapeutics Corporation announces the first successful transplant of a UThymoKidney™ into a living person, marking several historic milestones in transplantation. 💊 Gain Therapeutics reports positive results from the Phase 1 clinical trial of GT-02287, a therapy for GBA1 Parkinson’s Disease, showing good safety and tolerability profiles. 🚀 VIPC | Virginia Innovation Partnership Corporation (VIPC) appoints Joe Benevento as President & CEO to lead strategic initiatives driving innovation growth across Virginia. 📈 Alexandria Real Estate Equities, Inc. predicts a rebound in biotech investments, citing positive signs of recovery and strong performance in the sector. 💉 NIH's Small Business Innovative Research (SBIR) and Small Business Technology Transfer (STTR) programs offer over $1.3 billion annually to fund U.S. startups and support innovative healthcare solutions. 🏆 Association of University Research Parks (AURP) wins Stage One of the SBA's 2024 Growth Accelerator Fund Competition, receiving $50,000 for fostering entrepreneurship and R&D. 🌍 PitchBook ranks the world's top startup cities based on the size and maturity of their startup networks, aiding founders, operators, and investors in decision-making. ⚖️ Venable LLP is named to American Lawyer magazine’s 2024 Am Law 100 list, ranking #64 based on 2023 gross revenue. 🔬 Deloitte acquires Gryphon Scientific LLC to enhance its security, science, and public health capabilities, leveraging Gryphon's expertise in biosafety, biosecurity, and AI-driven solutions. All this and more at https://lnkd.in/es-Yst3E

I will be joining the Dutch Biotech Event! 💃   At ttopstart, we are your European life sciences and healthcare partner. We are devoted to the development of your research or innovation and will be joining the Dutch Biotech Event to participate in the interesting discussions, organised by hollandbio.   With our passionate team, we can support you with: ✍ Grant writing: looking for funding? ttopstart will help you with finding and applying for the right funds, whether you are a researcher or an entrepreneur! 🗓 Project management: ttopstart offers full project management support in your project(s). ✨ Sustainability: to sustain the developments within your project, it is important to establish a sustainability strategy. ttopstart helps with understanding your needs and guides you towards a sustainable approach. 📈 Business strategies: to ensure your ideas will become successful in the competitive landscape, our analyses can help with finding the right strategies for your ideas.   Want to know more? Feel free to reach out to me for an informal chat or find us at the Dutch Biotech Event!

„Growing fast, with a laser focus to market, Insempra might become the success story the synbio community needs right now.“ Thank you SynBioBeta, and John Cumbers for this great feature on our recent Series A funding round. 👉 Read the full article by clicking the link below

Introducing the next company presenting in our Innovation Showcase 2023: ArkVax, a London School of Hygiene and Tropical Medicine (LSHTM) spin-out, leveraging glycoengineering to develop next-gen vaccines for animal and humans. ArkVax’s proprietary Protein Glycan Coupling Technology (PGCT) is an all-in-one system for producing low-cost recombinant glycoconjugate vaccines at scale. The company’s platform can increase the efficacy of existing vaccines or rapidly generate new vaccines. ArkVax is developing its own pipeline of vaccines to address common diseases affecting livestock and further develop their platform. The company is actively seeking strategic partners and follow-on investment. Want to hear more from ArkVax' co-Founder and CEO Jon Cuccui? Sign up to our virtual event, or if you’d like to join us in person, just follow the FAQ on the event page to request a place: https://rb.gy/m74oa #LifeSciences #Biotech #Entrepreneurs #Investors #Innovation #StartUps

LAST 3 DAYS to apply for the EIT Health #Accelerator - Investment Readiness Support for CEE Start-ups and Scale-ups 🤝 What's in it for you? ✔ Customized support for high-potential start-ups to achieve investment readiness ✔ Increased visibility within a larger investor community ✔ Enhanced opportunities for growth and runway extension ✔ 25 companies will be invited to attend webinars on investment readiness topics ✔ Personalized one-on-one support from partners to improve the value proposition to investors 📌 You don't want to miss it! Hurry up! Deadline: June 28th, 2024 Apply on R2GConnect.com: https://bit.ly/4ckOx6L #Accelerator #Healthcare #Investment #Pitchingsupport

Attending #Bio Europe Spring again after some years has been inspiring. As former executive of a #Biotech company who now works as consultant for such companies, I enjoy learning about how much the Biotech environment has changed in #Europe and especially in #Spain. Six Spanish #Venturecapital entities organizing a joint together between companies and investors in globally is something that was a dream when I joined the sector in 2008. All of them are to be mentioned: Caixa Capital Risc, Asabys Partners, Invivo Partners, Ysios Capital, COLUMBUS VENTURE PARTNERS,S.G.E.I.C., S.A.U. and Aliath Bioventures I had the possibility to listen to many intriguing presentations from a wide range of perspectives: my friend Jose Mesa from COLUMBUS VENTURE PARTNERS,Sc.G.E.I.C., S.A.U. talked about their social view translated into the Fundación Columbus for treating children with #rarediseases. Clara Campàs Moya from Asabys Partners explained their investment strategy and how the impact of investments are measured from an #ESG perspective. Laura A. Lane from Eli Lilly and Company provided colour on their three-pilar strategy for investment and Alain Huriez Hureiz from AdBio partners gave his view as a foreign #VentureCapital investing in Spain. Lubor Gaal and Philippe Lopes-Fernandes gave concise advice, stating “Do not do it because of fashion” or “If you want to codevelop with pharma companies, have clear goals for such a cooperation or you will fail.” What does the future of #Biotech hold? I don’t know, but I leave this conference with new ideas and a sense of excitement for what is to come. 

Healthcare entrepreneurship is assuming an even greater role in driving innovation and sustainable solutions across the biotechnology industry. From the inception of fresh ideas and groundbreaking technologies to harnessing the power of transformation, Hayat Biotech is working towards reshaping healthcare as we know it.   Our CEO, Naser Al Yammahi, in an exclusive interview with Omnia Health, shares his experience as a leading healthcare entrepreneur and his commitment to building a sustainable future through the power of collaboration and innovation. Read the full article here https://lnkd.in/dGEBJ_jb #HealthcareBusinessGrowth #IndustryInnovations #ExpertAdvice #SustainableHealthcare #HayatBiotech #Hayatbiotech #Omniahealth

It’s a busy week for those in life sciences, you can catch our Healthcare Partner Sarah Meibusch at the following 👇   📅 Monday – AusBioInvest, Melbourne 👀 We can’t wait to hear Jennifer Nason of J.P. Morgan share her market outlook.   📅 Tuesday – The Bridge Program, Brisbane Launched in 2017, the program equips 100 researchers and entrepreneurs annually with the knowledge, skills, and networks needed to commercialise new pharmaceuticals.   Sarah’s joining to share her wisdom on the intersection with venture capital and how the ecosystem can support the commercialisation of the next generation of Australian Medicines.    📅 Wednesday to Friday – National AusBiotech Conference, Brisbane With the world’s BioTech Eyes on Australia, you can find Sarah speaking on the following: 🟠 Who's running this show? A guide to boards and shareholder agreements. 🟠 Hitchhiking along the long and winding investment road: who will the investors pick up and how to avoid being left behind. 🟠 You are what you eat - harnessing AI to power the Agribiotech value chain.   📅 Friday - Early-Stage Investment Forum @ AusBiotech Involved since its inception in 2018, you’ll find Sarah on the Selection Panel for this one.   🏆 We’re excited to see this year’s pitches. The Forum has been the genesis of several new spinouts from universities and new partnerships with pharma companies – good luck to those pitching! Life Sciences Queensland Ltd (LSQ) Queensland Government Advance Queensland

🧐 Are you a promising Central & Eastern European start-up in the life sciences sector, eager to scale your impact and attract investment? Attention: EIT Health has announced the #HICEE Call for promising ventures in #biotech, #medtech, and digital health! The Healthy Investment in Central Eastern Europe (HICEE) project aims to build a thriving #investment ecosystem across the region. This initiative focuses on empowering start-up support organizations, attracting local and international investors, and sharing success stories to boost cross-border collaboration. Strategically executed under the auspices of #HorizonEurope, the two-year initiative aims to catalyze sustainable economic growth and health innovation in the region. 🤝 What's in it for you? ✔ Customized support for high-potential start-ups to achieve investment readiness ✔ Increased visibility within a larger investor community ✔ Enhanced opportunities for growth and runway extension ✔ 25 companies will be invited to attend webinars on investment readiness topics ✔ Personalized one-on-one support from partners to improve the value proposition to investors 💥 Eight companies will be selected through pitching sessions to integrate into the EIT Health #Accelerator for longer-term support! 📌 You don't want to miss it! Hurry up! Deadline: June 28th, 2024 Apply on R2GConnect.com: https://bit.ly/4ckOx6L #globalhealth #healthcare #digitalhealth #innovationmanagement #opencall #investmentopportunity

An incredibly thought-provoking read in NZ Entrepreneur Magazine this week - Dr. Zahra Champion of BIOTech New Zealand, is joined by Stefan Korn, CEO of Callaghan Innovation, and our very own John Robson to give insight on the future of New Zealand's biotech industry and the pivotal role it plays in our position on the world stage 🇳🇿💪 🌏 They highlight the need for a comprehensive system that supports biotech growth, including policy and regulation, funding, resources, and expertise. With these critical elements in place, we can supercharge our biotech sector and help it thrive on the world stage. 📖 Dive into the full article to explore the exciting potential and challenges facing New Zealand's biotech future: https://lnkd.in/ggGcnAsd Let's keep the conversation going and work together to ensure a prosperous future for our biotech sector. 💪🔬 #BiotechInnovation #innovation #NewZealand #BridgewestVentures